Clinical significance linked to functional defects in bone morphogenetic protein type 2 receptor, BMPR2 |
Kim, Myung-Jin
(Department of Biological Sciences, Sookmyung Women's University)
Park, Seon Young (Department of Biological Sciences, Sookmyung Women's University) Chang, Hae Ryung (Department of Biological Sciences, Sookmyung Women's University) Jung, Eun Young (Department of Biological Sciences, Sookmyung Women's University) Munkhjargal, Anudari (Department of Biological Sciences, Sookmyung Women's University) Lim, Jong-Seok (Department of Biological Sciences, Sookmyung Women's University) Lee, Myeong-Sok (Department of Biological Sciences, Sookmyung Women's University) Kim, Yonghwan (Department of Biological Sciences, Sookmyung Women's University) |
1 | Nasim MT, Ghouri A, Patel B et al (2008) Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension. Hum Mol Genet 17, 1683-1694 DOI |
2 | Little SC and Mullins MC (2009) Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis. Nat Cell Biol 11, 637-643 DOI |
3 | Sun P, Wang J, Zheng Y, Fan Y and Gu Z (2012) BMP2/7 heterodimer is a stronger inducer of bone regeneration in peri-implant bone defects model than BMP2 or BMP7 homodimer. Dent Mater J 31, 239-248 DOI |
4 | Knaus P and Sebald W (2001) Cooperativity of binding epitopes and receptor chains in the BMP/TGFbeta superfamily. Biol Chem 382, 1189-1195 |
5 | Greenwald J, Groppe J, Gray P et al (2003) The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol Cell 11, 605-617 DOI |
6 | Harper RL, Reynolds AM, Bonder CS and Reynolds PN (2016) BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling. Respirology 21, 727-733 DOI |
7 | Zhang D, Mehler MF, Song Q and Kessler JA (1998) Development of bone morphogenetic protein receptors in the nervous system and possible roles in regulating trkC expression. J Neurosci 18, 3314-3326 DOI |
8 | Franzen A, Piek E, Westermark B, ten Dijke P and Heldin NE (1999) Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function. Endocrinology 140, 4300-4310 DOI |
9 | Rege J, Nishimoto HK, Nishimoto K, Rodgers RJ, Auchus RJ and Rainey WE (2015) Bone Morphogenetic Protein-4 (BMP4): A Paracrine Regulator of Human Adrenal C19 Steroid Synthesis. Endocrinology 156, 2530-2540 DOI |
10 | Wu X, Sagave J, Rutkovskiy A et al (2014) Expression of bone morphogenetic protein 4 and its receptors in the remodeling heart. Life Sci 97, 145-154 DOI |
11 | Bush KT, Sakurai H, Steer DL et al (2004) TGF-beta superfamily members modulate growth, branching, shaping, and patterning of the ureteric bud. Dev Biol 266, 285-298 DOI |
12 | Kang Q, Sun MH, Cheng H et al (2004) Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 11, 1312-1320 DOI |
13 | Howe JR, Bair JL, Sayed MG et al (2001) Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28, 184-187 DOI |
14 | Kim IY, Lee DH, Lee DK et al (2004) Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells. Oncogene 23, 7651-7659 DOI |
15 | Kodach LL, Wiercinska E, de Miranda NF et al (2008) The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Gastroenterology 134, 1332-1341 DOI |
16 | Schulz TJ and Tseng YH (2009) Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism. Cytokine Growth Factor Rev 20, 523-531 DOI |
17 | Mayeur C, Leyton PA, Kolodziej SA, Yu B and Bloch KD (2014) BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism. Blood 124, 2116-2123 DOI |
18 | Dichmann DS, Miller CP, Jensen J, Scott Heller R and Serup P (2003) Expression and misexpression of members of the FGF and TGFbeta families of growth factors in the developing mouse pancreas. Dev Dyn 226, 663-674 DOI |
19 | Razzouk S and Sarkis R (2012) BMP-2: biological challenges to its clinical use. N Y State Dent J 78, 37-39 |
20 | Luu HH, Song WX, Luo X et al (2007) Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 25, 665-677 DOI |
21 | Kanakaris NK and Giannoudis PV (2008) Clinical applications of bone morphogenetic proteins: current evidence. J Surg Orthop Adv 17, 133-146 |
22 | Sun J, Li J, Li C and Yu Y (2015) Role of bone morphogenetic protein-2 in osteogenic differentiation of mesenchymal stem cells. Mol Med Rep 12, 4230-4237 DOI |
23 | Hyun SJ, Han DK, Choi SH et al (2005) Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects. J Periodontol 76, 1667-1674 DOI |
24 | King JA, Marker PC, Seung KJ and Kingsley DM (1994) BMP5 and the molecular, skeletal, and soft-tissue alterations in short ear mice. Dev Biol 166, 112-122 DOI |
25 | Pi CJ, Liang KL, Ke ZY et al (2016) Adenovirus-mediated expression of vascular endothelial growth factor-a potentiates bone morphogenetic protein9-induced osteogenic differentiation and bone formation. Biol Chem 397, 765-775 |
26 | Daluiski A, Engstrand T, Bahamonde ME et al (2001) Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet 27, 84-88 |
27 | Hogan BL (1996) Bone morphogenetic proteins in development. Curr Opin Genet Dev 6, 432-438 DOI |
28 | Zhao GQ (2003) Consequences of knocking out BMP signaling in the mouse. Genesis 35, 43-56 DOI |
29 | Nohe A, Hassel S, Ehrlich M et al (2002) The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277, 5330-5338 DOI |
30 | Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI and Knaus P (2000) Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell 11, 1023-1035 DOI |
31 | Wrana JL, Attisano L, Carcamo J et al (1992) TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014 DOI |
32 | Koenig BB, Cook JS, Wolsing DH et al (1994) Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 14, 5961-5974 DOI |
33 | Miyazono K, Maeda S and Imamura T (2005) BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16, 251-263 DOI |
34 | Hassel S, Eichner A, Yakymovych M, Hellman U, Knaus P and Souchelnytskyi S (2004) Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 4, 1346-1358 DOI |
35 | Heldin CH and Moustakas A (2012) Role of Smads in TGFbeta signaling. Cell Tissue Res 347, 21-36 DOI |
36 | Murakami G, Watabe T, Takaoka K, Miyazono K and Imamura T (2003) Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell 14, 2809-2817 DOI |
37 | Zhu H, Kavsak P, Abdollah S, Wrana JL and Thomsen GH (1999) A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400, 687-693 DOI |
38 | Heinecke K, Seher A, Schmitz W, Mueller TD, Sebald W and Nickel J (2009) Receptor oligomerization and beyond: a case study in bone morphogenetic proteins. BMC Biol 7, 59 DOI |
39 | Nagashima T, Li Q, Clementi C, Lydon JP, DeMayo FJ and Matzuk MM (2013) BMPR2 is required for postimplantation uterine function and pregnancy maintenance. J Clin Invest 123, 2539-2550 DOI |
40 | Wiley DM and Jin SW (2011) Bone Morphogenetic Protein functions as a context-dependent angiogenic cue in vertebrates. Semin Cell Dev Biol 22, 1012-1018 DOI |
41 | Morrell NW (2006) Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling? Proc Am Thorac Soc 3, 680-686 DOI |
42 | Kim RY, Robertson EJ and Solloway MJ (2001) Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. Dev Biol 235, 449-466 DOI |
43 | Zhang H and Bradley A (1996) Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122, 2977-2986 |
44 | Winnier G, Blessing M, Labosky PA and Hogan BL (1995) Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9, 2105-2116 DOI |
45 | Jena N, Martin-Seisdedos C, McCue P and Croce CM (1997) BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye. Exp Cell Res 230, 28-37 DOI |
46 | Tillet E and Bailly S (2014) Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia. Front Genet 5, 456 |
47 | Rao SM, Ugale GM and Warad SB (2013) Bone morphogenetic proteins: periodontal regeneration. N Am J Med Sci 5, 161-168 DOI |
48 | Sieber C, Kopf J, Hiepen C and Knaus P (2009) Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev 20, 343-355 DOI |
49 | Lin SJ, Lerch TF, Cook RW, Jardetzky TS and Woodruff TK (2006) The structural basis of TGF-beta, bone morphogenetic protein, and activin ligand binding. Reproduction 132, 179-190 DOI |
50 | Ogata T, Wozney JM, Benezra R and Noda M (1993) Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc Natl Acad Sci U S A 90, 9219-9222 DOI |
51 | Ogata T and Noda M (1991) Expression of Id, a negative regulator of helix-loop-helix DNA binding proteins, is down-regulated at confluence and enhanced by dexamethasone in a mouse osteoblastic cell line, MC3T3E1. Biochem Biophys Res Commun 180, 1194-1199 DOI |
52 | Katagiri T, Imada M, Yanai T, Suda T, Takahashi N and Kamijo R (2002) Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 7, 949-960 DOI |
53 | Ito Y and Miyazono K (2003) RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev 13, 43-47 DOI |
54 | Maeda S, Hayashi M, Komiya S, Imamura T and Miyazono K (2004) Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J 23, 552-563 DOI |
55 | Lee S, Cho HY, Bui HT and Kang D (2014) The osteogenic or adipogenic lineage commitment of human mesenchymal stem cells is determined by protein kinase C delta. BMC Cell Biol 15, 42 DOI |
56 | Satija NK, Gurudutta GU, Sharma S et al (2007) Mesenchymal stem cells: molecular targets for tissue engineering. Stem Cells Dev 16, 7-23 DOI |
57 | Beppu H, Kawabata M, Hamamoto T et al (2000) BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev Biol 221, 249-258 DOI |
58 | Danesh SM, Villasenor A, Chong D, Soukup C and Cleaver O (2009) BMP and BMP receptor expression during murine organogenesis. Gene Expr Patterns 9, 255-265 DOI |
59 | Kim IY, Lee DH, Ahn HJ et al (2000) Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues. Cancer Res 60, 2840-2844 |
60 | Rigelsky CM, Jennings C, Lehtonen R, Minai OA, Eng C and Aldred MA (2008) BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia. Am J Med Genet A 146A, 2551-2556 DOI |
61 | Park SW, Hur SY, Yoo NJ and Lee SH (2010) Somatic frameshift mutations of bone morphogenic protein receptor 2 gene in gastric and colorectal cancers with microsatellite instability. APMIS 118, 824-829 DOI |
62 | Schleinitz D, Kloting N, Bottcher Y et al (2011) Genetic and evolutionary analyses of the human bone morphogenetic protein receptor 2 (BMPR2) in the pathophysiology of obesity. PLoS One 6, e16155 DOI |
63 | Wu M, Chen G and Li YP (2016) TGF-beta and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res 4, 16009 DOI |
64 | Miyazono K, Kamiya Y and Morikawa M (2010) Bone morphogenetic protein receptors and signal transduction. J Biochem 147, 35-51 DOI |
65 | Deng Z, Morse JH, Slager SL et al (2000) Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67, 737-744 DOI |
66 | van Dinther M, Visser N, de Gorter DJ et al (2010) ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMPinduced osteoblast differentiation and bone formation. J Bone Miner Res 25, 1208-1215 |
67 | Yoon BS, Ovchinnikov DA, Yoshii I, Mishina Y, Behringer RR and Lyons KM (2005) Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc Natl Acad Sci U S A 102, 5062-5067 DOI |
68 | Dyer LA, Pi X and Patterson C (2014) The role of BMPs in endothelial cell function and dysfunction. Trends Endocrinol Metab 25, 472-480 DOI |
69 | Amsalem AR, Marom B, Shapira KE et al (2016) Differential regulation of translation and endocytosis of alternatively spliced forms of the type II bone morphogenetic protein (BMP) receptor. Mol Biol Cell 27, 716-730 DOI |
70 | Lane KB, Machado RD, Pauciulo MW et al (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 26, 81-84 DOI |
71 | Rosenzweig BL, Imamura T, Okadome T et al (1995) Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A 92, 7632-7636 DOI |
72 | Sopory S, Nelsen SM, Degnin C, Wong C and Christian JL (2006) Regulation of bone morphogenetic protein-4 activity by sequence elements within the prodomain. J Biol Chem 281, 34021-34031 DOI |
73 | Lee KM, Tsai KY, Wang N and Ingber DE (1998) Extracellular matrix and pulmonary hypertension: control of vascular smooth muscle cell contractility. Am J Physiol 274, H76-82 |
74 | Atkinson C, Stewart S, Upton PD et al (2002) Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation 105, 1672-1678 DOI |
75 | Finkenzeller G, Hager S and Stark GB (2012) Effects of bone morphogenetic protein 2 on human umbilical vein endothelial cells. Microvasc Res 84, 81-85 DOI |
76 | Langenfeld EM and Langenfeld J (2004) Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2, 141-149 |
77 | Wiley DM, Kim JD, Hao J, Hong CC, Bautch VL and Jin SW (2011) Distinct signalling pathways regulate sprouting angiogenesis from the dorsal aorta and the axial vein. Nat Cell Biol 13, 686-692 DOI |
78 | de Jesus Perez VA, Alastalo TP, Wu JC et al (2009) Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. J Cell Biol 184, 83-99 DOI |
79 | Takahashi H, Goto N, Kojima Y et al (2006) Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 290, L450-458 DOI |
80 | Takahashi K, Kogaki S, Matsushita T, Nasuno S, Kurotobi S and Ozono K (2007) Hypoxia induces alteration of bone morphogenetic protein receptor signaling in pulmonary artery endothelial cell. Pediatr Res 61, 392-397 DOI |
81 | West J, Harral J, Lane K et al (2008) Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions. Am J Physiol Lung Cell Mol Physiol 295, L744-755 DOI |
82 | Hee CK and Nicoll S (2006) Induction of osteoblast differentiation markers in human dermal fibroblasts: potential application to bone tissue engineering. Conf Proc IEEE Eng Med Biol Soc 1, 521-524 |
83 | Onishi T, Ishidou Y, Nagamine T et al (1998) Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone 22, 605-612 DOI |
84 | Lehnerdt G, Metz KA, Trellakis S, Jahnke K and Neumann A (2007) Signaling by way of type IB and II bone morphogenetic protein receptors regulates bone formation in otospongiosis. Laryngoscope 117, 812-816 DOI |
85 | Garimella R, Kacena MA, Tague SE, Wang J, Horowitz MC and Anderson HC (2007) Expression of bone morphogenetic proteins and their receptors in the bone marrow megakaryocytes of GATA-1(low) mice: a possible role in osteosclerosis. J Histochem Cytochem 55, 745-752 DOI |
86 | Yang C, Yang L, Wan M and Cao X (2010) Generation of a mouse model with expression of bone morphogenetic protein type II receptor lacking the cytoplasmic domain in osteoblasts. Ann N Y Acad Sci 1192, 286-291 DOI |
87 | Katagiri T, Yamaguchi A, Komaki M et al (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127, 1755-1766 DOI |
88 | Davis RL, Weintraub H and Lassar AB (1987) Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987-1000 DOI |
89 | Wright WE, Sassoon DA and Lin VK (1989) Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56, 607-617 DOI |
90 | Edmondson DG and Olson EN (1990) A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev 4, 1450 DOI |
91 | Olson EN (1990) MyoD family: a paradigm for development? Genes Dev 4, 1454-1461 DOI |
92 | Yang J, Davies RJ, Southwood M et al (2008) Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Circ Res 102, 1212-1221 DOI |
93 | Katagiri T, Yamaguchi A, Ikeda T et al (1990) The nonosteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 172, 295-299 DOI |
94 | Wu N, Zhao Y, Yin Y, Zhang Y and Luo J (2010) Identification and analysis of type II TGF-beta receptors in BMP-9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. Acta Biochim Biophys Sin (Shanghai) 42, 699-708 DOI |
95 | Morrell NW (2010) Role of bone morphogenetic protein receptors in the development of pulmonary arterial hypertension. Adv Exp Med Biol 661, 251-264 |
96 | Hamid R, Hedges LK, Austin E, Phillips JA 3rd, Loyd JE and Cogan JD (2010) Transcripts from a novel BMPR2 termination mutation escape nonsense mediated decay by downstream translation re-initiation: implications for treating pulmonary hypertension. Clin Genet 77, 280-286 DOI |
97 | Ihida-Stansbury K, McKean DM, Lane KB et al (2006) Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 291, L694-702 DOI |
98 | Drake KM, Dunmore BJ, McNelly LN, Morrell NW and Aldred MA (2013) Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension. Am J Respir Cell Mol Biol 49, 403-409 DOI |